Biphasic versus triphasic oral contraceptives for contraception

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 6, 2006, Pages

  Van Vliet, Huib AAM ^a   Grimes, David A ^b   Helmerhorst, Frans M ^a   Schulz, Kenneth F ^b   Lopez, Laureen M ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; LEVONORGESTREL; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; MENSTRUATION; MENSTRUATION DISORDER; RANDOMIZED CONTROLLED TRIAL; REVIEW;

CONTRACEPTION; CONTRACEPTIVES, ORAL, SYNTHETIC; ETHINYL ESTRADIOL; FEMALE; HUMANS; LEVONORGESTREL; MENSTRUATION; MENSTRUATION DISTURBANCES; NORETHINDRONE; RANDOMIZED CONTROLLED TRIALS;

EID: 33750122628     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003283.pub2     Document Type: Review

References (14)

1. Larranaga A, Sartoretto JN, Winterhalter M, Navas Filho F. Clinical evaluation of two biphasic and one triphasic norgestrel/ethinyl estradiol regimens. International Journal of Fertility 1978;23:193-9.
2. Percival-Smith RK, Yuzpe AA, Desrosiers JA, Rioux JE, Guilbert E. Cycle control on low-dose oral contraceptives: a comparative trial. Contraception 1990;42:253-62.
3. Briggs M, Briggs M. A randomized study of metabolic effects of four oral contraceptive preparations containing levonorgestrel plus ethinylestradiol in different regimens. The development of a new triphasic oral contraceptive. Proceedings of a Special Symposium held at the 10th World Congress on Fertility and Sterility; 1980 July; Madrid. Lancaster (England): MTP Press, 1980:79-88.
4. Briggs MH, Briggs M. Randomized prospective studies on metabolic effects of oral contraceptives. Acta Obstetrica et Gynecologica Scandinavica Supplement 1982;105:25-32.
5. Castaigne JP. Triella: a French multicenter double blind clinical study [Triella-Etude clinique multicentrique francaise menee en double aveugle]. Contraception, Fertilité, Sexualité 1985;13 Suppl:445-53.
6. Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel. Contraception 1983;27:577-90.
7. Droegemueller W, Katta LR, Bright TG, Bowes WA Jr. Triphasic randomized clinical trial: comparative frequency of intermenstrual bleeding. American Journal of Obstetrics and Gynecology 1989;161:1407-11.
8. Hillard PJ. Oral contraception noncompliance: the extent of the problem. Advances in Contraception 1992;8(Suppl 1):13-20.
9. Mishell DR. Oral contraception: past, present, and future perspectives. International Journal of Fertility 1991;36 Suppl:7-18.
10. Rossiter EJR. Reflections of a whistle-blower. Nature 1992;357:434-6.
11. Schilling LH, Bolding OT, Chenault CB, Chong AP, Fleury F, Forrest K, et al. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial. American Journal of Obstetrics and Gynecology 1989;160(5 Pt 2):1264-8.
12. Upton GV. The phasic approach to oral contraception: the triphasic concept and its clinical application. International Journal of Fertility 1983;28:121-40.
13. Wallach M, Grimes DA, Chaney EJ, Connell EB, Creinin MD, Emans SJ, et al. Modern Oral Contraception. Totowa (NJ): Emron, Inc., 2000.
14. Van Vliet H, Grimes D, Helmerhorst F, Schulz K. Biphasic versus triphasic oral contraceptives for contraception. Contraception 2002;65:321-4.